Chronic urticaria (CU) is a dermatological condition characterized by recurrent wheals (hives), angioedema (deep tissue swelling), or both, persisting for over 6 weeks. 1 Unlike acute urticaria, which ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

—The identification of chronic spontaneous urticaria (CSU) endotypes has improved understanding of the heterogeneity of the disease and the underlying pathogenic mechanisms to inform diagnosis and ...

A massive global study has ranked the best and safest treatments for chronic hives when antihistamines fall short. The findings provide a clear treatment roadmap for both patients and clinicians alike ...

Please provide your email address to receive an email when new articles are posted on . Barzolvolimab binds receptor tyrosine kinase KIT to inhibit its activity, which mast cells need for survival.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Barzolvolimab prevents the binding of stem cell factor ...

Hives (urticaria) are raised, itchy bumps on your skin. If you get itchy hives that come and go mostly every day for over six weeks, you might have a skin condition known as chronic spontaneous ...

Rilzabrutinib significantly alleviates itch and hives in patients with CSU unresponsive to H1-antihistamines, offering a potential new treatment option. The RILECSU trial demonstrated significant ...

Detailed price information for Celldex Therapeutics (CLDX-Q) from The Globe and Mail including charting and trades.

Dr Adam Friedman anticipates that AAD will highlight a shift in CSU treatment toward precision medicine, using targeted ...

Detailed price information for Celldex Therapeutics (CLDX-Q) from The Globe and Mail including charting and trades.